Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
159.12 Up 0.13(0.08%) Aug 1, 3:59PM EDT
|After Hours : 159.12 0.00 (0.00%) Aug 1, 5:23PM EDT
Prev Close:158.99
Open:158.62
Bid:156.21 x 100
Ask:163.00 x 100
1y Target Est:197.05
Beta:0.51
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:156.21 - 161.11
52wk Range:100.89 - 185.43
Volume:1,160,307
Avg Vol (3m):1,202,190
Market Cap:31.48B
P/E (ttm):96.20
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 0.08%31.48B
AMGNDown 1.44%95.29B
BAXUp 0.37%40.68B

Key Statistics

Forward P/E (1 yr):27.48
P/S (ttm):16.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback